Jennifer Simpson
Chief Executive Officer bei PANBELA THERAPEUTICS, INC.
Vermögen: 572 $ am 31.03.2024
Profil
Jennifer K.
Simpson is currently the President, Chief Executive Officer & Director at Panbela Therapeutics, Inc. She is also the Chairman at LadRx Corp.
and the Lead Independent Director at Eagle Pharmaceuticals, Inc. Previously, she served as the President, Chief Executive Officer & Director at Delcath Systems, Inc. from 2015 to 2020.
She was also the Product Director-Oncology Therapeutics Marketing at Janssen Biotech, Inc. from 2006 to 2008 and the VP-Global Marketing, Oncology Brand at ImClone LLC from 2011 to 2012.
Dr. Simpson holds a graduate degree from Rochester Christian University, a doctorate degree from the University of Pittsburgh, and an undergraduate degree from the State University of New York at Buffalo.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
LADRX CORPORATION
0,05% | 15.01.2024 | 250 ( 0,05% ) | 568 $ | 31.03.2024 |
PANBELA THERAPEUTICS INC
0,00% | 27.03.2024 | 7 ( 0,00% ) | 5 $ | 31.03.2024 |
| 31.03.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Jennifer Simpson
| Unternehmen | Position | Beginn |
|---|---|---|
| EAGLE PHARMACEUTICALS, INC. | Director/Board Member | 28.08.2019 |
| PANBELA THERAPEUTICS, INC. | Chief Executive Officer | 16.07.2020 |
| LADRX CORPORATION | Chairman | 27.07.2022 |
Ehemalige bekannte Positionen von Jennifer Simpson
| Unternehmen | Position | Ende |
|---|---|---|
| DELCATH SYSTEMS, INC. | Chief Executive Officer | 01.06.2020 |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | 01.01.2011 |
Janssen Biotech, Inc.
 Janssen Biotech, Inc. Pharmaceuticals: MajorHealth Technology Janssen Biotech, Inc. engages in the development and marketing of prescription drugs. The company is headquartered in Horsham, PA. | Sales & Marketing | 01.01.2008 |
Ausbildung von Jennifer Simpson
| Rochester Christian University | Graduate Degree |
| University of Pittsburgh | Doctorate Degree |
| State University of New York at Buffalo | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| LADRX CORPORATION | Health Technology |
| DELCATH SYSTEMS, INC. | Health Technology |
| EAGLE PHARMACEUTICALS, INC. | Health Technology |
| PANBELA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
Janssen Biotech, Inc.
Janssen Biotech, Inc. Pharmaceuticals: MajorHealth Technology Janssen Biotech, Inc. engages in the development and marketing of prescription drugs. The company is headquartered in Horsham, PA. | Health Technology |
